In a patient with radiation‑induced cystitis presenting with gross hematuria, should a suprapubic catheter be used to improve bleeding, or is hyperbaric oxygen therapy still the recommended primary treatment?

Hyperbaric Oxygen Therapy Remains the Recommended Primary Treatment for Radiation-Induced Hemorrhagic Cystitis

For gross hematuria from radiation-induced cystitis, hyperbaric oxygen therapy (HBOT) is the recommended primary treatment—a suprapubic catheter serves only as a supportive measure for clot evacuation and bladder drainage, not as a therapeutic intervention to improve the underlying bleeding. 1

Treatment Algorithm for Radiation-Induced Hemorrhagic Cystitis

Initial Management

The 2024 AIRO guidelines explicitly state that treatment for hemorrhagic cystitis includes hydration, hyperbaric oxygen, clot evacuation, endoscopic fulguration, and bladder irrigation 1. Notably, suprapubic catheterization is not mentioned as a primary therapeutic modality—it functions purely as a drainage mechanism when transurethral catheterization fails or when clot burden is severe.

Why HBOT is the Primary Treatment

HBOT addresses the fundamental pathophysiology of radiation cystitis by:

• Inducing neo-vascularization to repair radiation-damaged blood vessels
• Promoting tissue re-oxygenation in the chronically hypoxic bladder wall
• Stimulating collagen neo-deposition and fibroblast proliferation for tissue healing 1

The underlying mechanism of radiation-induced hemorrhagic cystitis is vascular endothelial cell damage that develops with a latency period of 1-25 years, causing progressive ischemia and friable mucosa 1. A suprapubic catheter cannot reverse this vascular injury—it merely provides urinary diversion.

Evidence Supporting HBOT Efficacy

Recent high-quality evidence demonstrates:

• 66-100% of patients achieve at least partial response to HBOT 2
• 84-86.8% complete response rates when initiated early 3, 4
• Critical timing factor: All patients achieving complete response received therapy within 6 months of hematuria onset 3, 5
• Durable results: 96% freedom from significant hematuria at follow-up 4
• Safe even in elderly: Successful treatment documented in a 95-year-old patient with severe bleeding 6

Treatment Protocol

HBOT parameters:

• Pressure: 2.0-2.5 atmospheres absolute (ATA)
• Duration: 90-120 minutes per session
• Frequency: Daily sessions
• Total sessions: Median 30-33 sessions (range 10-48) 3, 7, 4
• Response timing: Clinical improvement typically begins during initial sessions 7

Role of Suprapubic Catheter

A suprapubic catheter should be considered only when:

1. Clot retention causes bladder outlet obstruction requiring continuous irrigation
2. Transurethral catheterization fails or is contraindicated
3. Concurrent need for bladder irrigation with hemostatic agents

The catheter itself does not improve bleeding—it facilitates clot evacuation and allows for continuous bladder irrigation, which are supportive measures while definitive therapy (HBOT) takes effect.

Stepwise Approach

For gross hematuria from radiation cystitis:

1. Immediate stabilization: Hydration, transfusion if needed, urethral or suprapubic catheter for clot evacuation
2. Rule out malignancy: Cystoscopy to exclude recurrent cancer (mandatory before attributing bleeding to radiation) 1
3. Initiate HBOT within 6 months of hematuria onset for optimal outcomes 3, 5
4. Concurrent measures: Bladder irrigation with various substances as needed
5. Endoscopic fulguration: If bleeding persists despite HBOT or for focal bleeding sites 1
6. Surgery: Reserved for refractory disease after HBOT failure 1

Critical Pitfalls to Avoid

• Delaying HBOT: Waiting beyond 6 months significantly reduces complete response rates 3, 5
• Relying on catheter alone: This provides drainage but does not address the underlying vascular pathology
• Premature surgery: Cystectomy should only be considered after HBOT failure, as 84-87% respond to HBOT 3, 4
• Inadequate sessions: Stopping HBOT prematurely—median 30-33 sessions needed for complete response 3, 7

Safety Profile

HBOT is well-tolerated with complications limited to:

• Otic barotrauma (most common—eardrum perforation in ~12% of cases) 2, 4
• Transient vertigo (rare)
• Mild hemoptysis (rare)

None typically require treatment discontinuation 4.

Quality of Life Impact

Beyond controlling hematuria, HBOT improves urinary symptoms and overall quality of life measures 2, addressing the broader impact of radiation cystitis on bladder function. This represents a significant advantage over purely mechanical interventions like catheterization.

Bottom line: Suprapubic catheterization is an adjunctive drainage procedure, not a treatment for radiation-induced hemorrhagic cystitis. HBOT remains the evidence-based primary therapy that addresses the underlying vascular pathology and should be initiated within 6 months of hematuria onset for optimal outcomes.